Federal Judge Issues Criminal Sentencing to Purdue Pharma in DOJ Probe Resolution

A federal judge has issued a criminal sentencing to OxyContin maker Purdue Pharma, resolving a probe by the U.S. Department of Justice. This action serves as the final step in a legal settlement that addresses thousands of lawsuits filed against the company.

The settlement involves a guilty plea and civil agreement with the federal government. The settlement includes $8.3 billion in forfeitures, fines, and penalties. However, the federal government has agreed to collect only $225 million, contingent on Purdue Pharma reaching a separate settlement with the parties in the other lawsuits.

Members of the Sackler family, who own Purdue Pharma, have agreed to contribute up to $7 billion over 15 years as part of resolving those additional lawsuits. The overall agreement aims to address claims related to the company's role in the opioid crisis. Purdue Pharma produces OxyContin, a prescription painkiller linked to numerous legal actions.

The lawsuits stem from allegations that Purdue Pharma contributed to widespread opioid misuse in the United States. With this criminal sentencing, the company can proceed with restructuring under the terms of the settlements. Future payments and distributions will depend on the fulfillment of the agreed conditions.